000 | 01389 a2200421 4500 | ||
---|---|---|---|
005 | 20250512192258.0 | ||
264 | 0 | _c19670531 | |
008 | 196705s 0 0 eng d | ||
022 | _a0003-9993 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKantor, T G | |
245 | 0 | 0 |
_aMedical management of patients with disability due to arthritis. _h[electronic resource] |
260 |
_bArchives of physical medicine and rehabilitation _cMar 1967 |
||
300 |
_a142-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xtherapeutic use |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntimalarials _xtherapeutic use |
650 | 0 | 4 |
_aArthritis, Infectious _xtherapy |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xtherapy |
650 | 0 | 4 |
_aAspirin _xtherapeutic use |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGold _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndomethacin _xtherapeutic use |
650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOrthopedics |
650 | 0 | 4 |
_aOsteoarthritis _xtherapy |
650 | 0 | 4 |
_aPhenylbutazone _xtherapeutic use |
650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
773 | 0 |
_tArchives of physical medicine and rehabilitation _gvol. 48 _gno. 3 _gp. 142-4 |
|
999 |
_c6021707 _d6021707 |